Medicare News

Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Increasingly, new technologies are making it possible to carefully identify sets of patien
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize

September 25, 2007 — 5:59am ET

The pink slips are starting to go out at Amgen. In a follow-up to the biotech giant's announced restructuring, Amgen is laying Read more...

Free Newsletter